Published in Exp Clin Psychopharmacol on May 01, 1999
A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med (2008) 4.57
A randomised control study of a fully automated internet based smoking cessation programme. Tob Control (2006) 3.17
Menstrual phase effects on smoking relapse. Addiction (2008) 2.33
Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol (2007) 1.94
The early time course of smoking withdrawal effects. Psychopharmacology (Berl) (2006) 1.90
Subjective social status affects smoking abstinence during acute withdrawal through affective mediators. Addiction (2010) 1.60
Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender. Exp Clin Psychopharmacol (2006) 1.59
Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine Tob Res (2010) 1.58
Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am J Addict (2012) 1.25
Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey. Nicotine Tob Res (2015) 1.11
Stress- and cue-induced cigarette craving: effects of a family history of smoking. Drug Alcohol Depend (2006) 1.06
Sex differences in negative affect and lapse behavior during acute tobacco abstinence: a laboratory study. Exp Clin Psychopharmacol (2013) 1.04
The influence of subjective social status on vulnerability to postpartum smoking among young pregnant women. Am J Public Health (2007) 1.02
Sex differences in anxiety-like behavior and locomotor activity following chronic nicotine exposure in mice. Neurosci Lett (2008) 1.00
Subjective responses to intravenous nicotine: greater sensitivity in women than in men. Exp Clin Psychopharmacol (2009) 0.96
The Smoking Consequences Questionnaire: Factor structure and predictive validity among Spanish-speaking Latino smokers in the United States. Nicotine Tob Res (2009) 0.93
Gender differences among hardcore smokers: an analysis of the tobacco use supplement of the current population survey. J Womens Health (Larchmt) (2008) 0.89
Sex heterogeneity in pharmacogenetic smoking cessation clinical trials. Drug Alcohol Depend (2009) 0.89
The many faces of tobacco use among women. Med Sci Monit (2014) 0.86
Gender Differences in Quit Support by Partners of Health-Compromised Smokers. J Drug Issues (2009) 0.86
Epidemiology, determinants, and consequences of cigarette smoking in African American women: an integrative review. Addict Behav (2009) 0.85
Residential smoking restrictions are not associated with reduced child SHS exposure in a baseline sample of low-income, urban African Americans. Health (Irvine Calif) (2010) 0.85
Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Nicotine Tob Res (2015) 0.84
Gender differences in responses to cues presented in the natural environment of cigarette smokers. Nicotine Tob Res (2015) 0.83
Design of a randomized controlled trial for multiple cancer risk behaviors among Spanish-speaking Mexican-origin smokers. BMC Public Health (2013) 0.82
Innovations in translational sex and gender-sensitive tobacco research. Nicotine Tob Res (2015) 0.81
Subjective sleep disturbance during a smoking cessation program: associations with relapse. Addict Behav (2011) 0.81
Consideration of sex in clinical trials of transdermal nicotine patch: a systematic review. Exp Clin Psychopharmacol (2014) 0.81
Positive smoking outcome expectancies mediate the association between negative affect and smoking urge among women during a quit attempt. Exp Clin Psychopharmacol (2014) 0.80
Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users. Exp Clin Psychopharmacol (2015) 0.80
Expectancies for the effectiveness of different tobacco interventions account for racial and gender differences in motivation to quit and abstinence self-efficacy. Nicotine Tob Res (2014) 0.79
Gender differences in self-reported withdrawal symptoms and reducing or quitting smoking three years later: A prospective, longitudinal examination of U.S. adults. Drug Alcohol Depend (2016) 0.78
Effect of direct physician involvement on tobacco abstinence rates and other variables affecting participants of a freedom from tobacco class. Perm J (2013) 0.75
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med (1999) 10.62
The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA (1994) 6.02
Trends in cigarette smoking in the United States. Educational differences are increasing. JAMA (1989) 5.59
Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA (1997) 5.47
Trends in cigarette smoking in the United States. Projections to the year 2000. JAMA (1989) 4.90
Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA (1994) 3.83
Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA (1992) 3.77
The reliability of self-reported cigarette consumption in the United States. Am J Public Health (1989) 3.35
Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol (1999) 3.21
Gender differences in smoking cessation. J Consult Clin Psychol (1999) 2.84
Varying nicotine patch dose and type of smoking cessation counseling. JAMA (1995) 2.82
Sleep apnea and hypertension. A population-based study. Ann Intern Med (1994) 2.79
The motivation to use drugs: a psychobiological analysis of urges. Nebr Symp Motiv (1986) 2.56
Cigarette smoking prevalence by occupation in the United States. A comparison between 1978 to 1980 and 1987 to 1990. J Occup Med (1994) 2.52
US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care (2000) 2.44
Quitting smoking in the United States in 1986. J Natl Cancer Inst (1990) 2.42
Smoking status as the new vital sign: effect on assessment and intervention in patients who smoke. Mayo Clin Proc (1995) 2.32
Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care (1999) 2.28
Postcessation cigarette use: the process of relapse. Addict Behav (1990) 2.21
Smoking withdrawal dynamics in unaided quitters. J Abnorm Psychol (2000) 2.11
Smoking outcome expectancies: factor structure, predictive validity, and discriminant validity. J Abnorm Psychol (1994) 2.06
Time-dependence of hazard ratios for prognostic factors in primary breast cancer. Breast Cancer Res Treat (1998) 1.85
Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms. J Abnorm Psychol (1998) 1.84
Smoking cessation treatment and the good doctor club. Am J Public Health (1995) 1.60
Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med (1994) 1.59
Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med (1999) 1.54
Urinary tract cancers found by homescreening with hematuria dipsticks in healthy men over 50 years of age. Cancer (1989) 1.53
Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology (1995) 1.48
Nicotine dependence, withdrawal symptoms, and adolescents' readiness to quit smoking. Nicotine Tob Res (2001) 1.47
The relation between cigarette smoking and sleep disturbance. Prev Med (1994) 1.45
Trends in smoking by age and sex, United States, 1974-1987: the implications for disease impact. Prev Med (1990) 1.35
Scheduled reduced smoking: effects on smoking abstinence and potential mechanisms of action. Addict Behav (1998) 1.32
Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. Prev Med (1998) 1.31
Relation between self-reported affect and drug urges and cravings in continuing and withdrawing smokers. J Abnorm Psychol (1992) 1.29
Epidemiologic study of drinking water chlorination and Wisconsin female cancer mortality. J Natl Cancer Inst (1981) 1.27
Gender and racial/ethnic differences in tobacco-dependence treatment: a commentary and research recommendations. Nicotine Tob Res (2001) 1.20
Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. J Consult Clin Psychol (1992) 1.19
Any further progress in smoking cessation treatment? Nicotine Tob Res (2001) 1.18
Manipulating smoking motivation: impact on an electrophysiological index of approach motivation. J Abnorm Psychol (1999) 1.17
Assessing the generalizability of smoking studies. Addiction (1997) 1.17
Case-control study of colon cancer and drinking water trihalomethanes in Wisconsin. Int J Epidemiol (1987) 1.16
Psychological distress and patient satisfaction. Med Care (1982) 1.16
Drinking water treatment and risk of cancer death in Wisconsin. Environ Health Perspect (1982) 1.15
Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation. Prev Med (2000) 1.14
Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest (1994) 1.13
Smoking cessation: recent developments in behavioral and pharmacologic interventions. Oncology (Williston Park) (1998) 1.10
Smokeless tobacco use in the United States: the adult use of tobacco surveys. NCI Monogr (1989) 1.09
The significance of asymptomatic microhematuria in men 50 or more years old: findings of a home screening study using urinary dipsticks. J Urol (1987) 1.08
Hematuria home screening: repeat testing results. J Urol (1995) 1.04
The epidemiology of tobacco use, dependence, and cessation in the United States. Prim Care (1999) 1.04
Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacology (Berl) (1996) 1.04
Prognostic factors for the elderly with proximal femoral fracture. Arch Emerg Med (1984) 0.99
Tobacco withdrawal and nicotine replacement influence objective measures of sleep. J Consult Clin Psychol (1995) 0.98
Under-use of tobacco dependence treatment among Wisconsin's fee-for-service Medicaid recipients. WMJ (2001) 0.96
Aversion instead of preference learning indicated by nicotine place conditioning in rats. Psychopharmacology (Berl) (1990) 0.93
Morphine tolerance as habituation. Psychol Rev (1985) 0.92
An evaluation of videotaped vignettes for smoking cessation and relapse prevention during pregnancy: the very important pregnant smokers (VIPS) program. Tob Control (2000) 0.91
Conservative treatment of fractures and fracture-dislocations of the upper end of the humerus. J Bone Joint Surg Br (1985) 0.91
An epidemiologic study of oral cancer in a statewide network. Am J Otolaryngol (1986) 0.90
Blood pressure perturbations caused by subclinical sleep-disordered breathing. Sleep (1998) 0.90
Home screening for hematuria: results of a multiclinic study. J Urol (1992) 0.89
Strike while the iron is hot: can stepped-care treatments resurrect relapsing smokers? J Consult Clin Psychol (2001) 0.89
Subjective dimensions of heroin urges: influence of heroin-related and affectively negative stimuli. Addict Behav (1989) 0.89
Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. Pharmacogenomics J (2011) 0.87
The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. Findings and implications for psychologists. Am Psychol (1998) 0.85
Gastric cancer mortality and nitrate levels in Wisconsin drinking water. Arch Environ Health (1992) 0.85
A validation study of body fat distribution as determined by self-measurement of waist and hip circumference. Int J Obes (1989) 0.85
A dynamic mathematical model of the chemostat. Biotechnol Bioeng (1970) 0.84
Automated detection and classification of sleep-disordered breathing from conventional polysomnography data. Sleep (1997) 0.84
Principal components analysis of the inventory of drinking situations: empirical categories of drinking by alcoholics. Addict Behav (1990) 0.84
Smoking cessation: principles and practice based upon the AHCPR Guideline, 1996. Agency for Health Care Policy and Research. Ann Behav Med (1997) 0.84
An indication for human tetanus immunoglobulin in unimmunized patients. Arch Emerg Med (1985) 0.84
Treating cigarette smoking with smokeless tobacco: a flawed recommendation. Am J Med (1998) 0.83
Youth tobacco sale compliance checks: impact on vendor practices and community policy. Wis Med J (1996) 0.83
The tyranny of habit and availability. Addiction (1999) 0.83
The Agency for Health Care Policy and Research smoking cessation clinical practice guideline: basics and beyond. Prim Care (1999) 0.83
Does smoking amortize negative affect? Am Psychol (2000) 0.82
Effects of maintenance sessions on smoking relapse: delaying the inevitable? J Consult Clin Psychol (1987) 0.81
Prevalence of daily and experimental smoking among University of Wisconsin-Madison undergraduates, 1989-1993. Wis Med J (1993) 0.81
Effect of preconditioning unconditioned stimulus experience on learned taste aversions. J Exp Psychol Anim Behav Process (1975) 0.81
Staging of malignant lymphoma by laparotomy and splenectomy: review of the literature. Mil Med (1972) 0.80